Navigation Links
Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
Date:9/18/2009

COLLEGEVILLE, Pa. and SAN DIEGO, Sept. 18 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.

Ambrx anticipates earning near term payments from an upfront commitment, target loading fees and research funding. In addition, Ambrx will be eligible to receive escalating preclinical, clinical, regulatory and commercial milestone payments as well as tiered royalties on sales of products resulting from the collaboration.

"This collaboration with Ambrx reinforces Wyeth's commitment to sustaining and growing our already robust capabilities in the field of biologics drug discovery through partnerships with biotech innovators," said Mikael Dolsten, M.D., Ph.D., President, Wyeth Research. "We are enthusiastic about working with Ambrx, a company with the ability to create and advance precisely engineered biologic drug candidates into clinical trials using its proprietary platform."

Stephen Kaldor, Ph.D., President and CEO of Ambrx, said: "Wyeth is a long-standing leader in protein therapeutics with a strong record of successfully developing innovative products. We are pleased that Wyeth recognizes the power of the Ambrx EuCODE(TM) platform and look forward to collaborating with Wyeth's talented personnel to produce the next generation of biologic drugs."

About Ambrx

Ambrx Inc. is a clinical stage biopharmaceutical
'/>"/>

SOURCE Ambrx Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... are often treated with hormones, but when the tumours ... vessels, reveals a thesis from the Sahlgrenska Academy, at ... way for new treatments for hormone-resistant prostate cancer. , ... prostate cancer has spread, most patients are given hormone ... hormone and the tumour shrinks. , "The problem is ...
(Date:12/15/2009)... An international team of Canadian and Spanish scientists have ... people develop severe pneumonia when infected by the pandemic ... of regulating molecules for 20 hospitalized patients, 15 outpatients ... the first pandemic wave in July and August 2009. ... Spain and the University Health Network found high levels ...
(Date:12/15/2009)... the volume without compromising sound-quality or comfort. , ... ... EarPeace ( www.earpeace.com ) is redefining hearing protection with high-fidelity, ... skin-tone colors. "As a big fan of live-music and having ... for a way to continue my active lifestyle in a ...
(Date:12/15/2009)... , ... New York, NY (Vocus) ... augmentation and other large-volume body enhancing injections on blog sites ... potentially deadly trend, cautions the Physicians Coalition for Injectable ... and polyacrylimide used in augmenting buttocks, hips, and even breasts ...
(Date:12/15/2009)... study finds , , TUESDAY, Dec. 15 (HealthDay News) -- Tight ... with type 2 diabetes who have other medical problems, a ... in type 2 diabetes "has been a subject of controversy ... medicine at the University of California at Irvine, and lead ... the Annals of Internal Medicine . "Our work attempts ...
Breaking Medicine News(10 mins):Health News:More blood vessels in hormone-resistant prostate tumors 2Health News:First immunological clue to why some H1N1 patients get very ill or die 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4Health News:Tighter Blood Sugar Control Not Best for Some Diabetics 2Health News:Tighter Blood Sugar Control Not Best for Some Diabetics 3
... , TUESDAY, Dec. 18 (HealthDay News) -- A new ... cancer involving the tonsils, researchers say. , According to ... robotic surgery (TORS) system includes three instrument-holding robotic arms ... instrument with two video cameras that offers a three-dimensional ...
... in the December issue of The Journal of the ... cancer operations in 80-year-olds are considerably worse than reported ... lead to unrealistic expectations about the safety of these ... patients and their physicians may have difficulty accurately assessing ...
... (Nasdaq and SWX: BMRN) announced today that it ... (sapropterin dihydrochloride), from Merck Serono, a division of,Merck ... molecule for the,treatment of phenylketonuria (PKU) developed in ... are approximately 1,200 to,1,500 people under the age ...
... one of,more than 400,000 people in the U.S. and ... debilitating disease that causes,paralysis, blindness, incontinence and cognitive dysfunction ... founder of the Accelerated,Cure Project for Multiple Sclerosis, is ... funds he needs to scratch "Develop a cure for ...
... 2007 UT Southwestern Medical Center researchers have found that ... excludes a group of obese patients at risk of cardiovascular ... of the journal Surgery for Obesity and Related Diseases, ... between body mass index (BMI) and cardiovascular disease as it ...
... and Implantability Characteristics, MINNEAPOLIS, Dec. 18 ... manufacturer and marketer of state-of-the-art cardiac,surgery products ... Drug,Administration (FDA) approval for the ATS Open ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), The ATS AP360 heart ...
Other Medicine News:Health News:Robotic Surgery Treats Tonsil Cancer 2Health News:Study finds outcomes of high-risk cancer operations in 80-year-olds worse than reported 2Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 2Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 3Health News:BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono 4Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 2Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 3Health News:BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest 2Health News:ATS Medical Receives FDA Approval for AP360 Mechanical Heart Valve 2Health News:ATS Medical Receives FDA Approval for AP360 Mechanical Heart Valve 3
(Date:12/15/2009)... BEIJING, Dec. 15 /PRNewswire-Asia/ -- Sinovac Biotech ... products in China, announced today,that Weidong Yin, ... China Central,Television (CCTV) to be one of ... CCTV,s Economic Man-of-the-Year ... award, sometimes referred to as the "Oscar ...
(Date:12/15/2009)... Dec. 15 Accumetrics, Inc., developer and ... and easy-to-use diagnostic system for measuring an individual,s ... included a doubling in the number of international ... medical community support, and significant capital financing that ... In 2009, the company continued its commitment to ...
(Date:12/15/2009)... Mass., Dec. 15 OBP Medical Inc. ... and overall patient satisfaction in hospitals. ,, Doctors ... the positive effects of OBP Medical,s Under Johnnies(TM) ... stay. A hospital wide survey is comparing patients, ... their stay while wearing Under Johnnies(TM) against the ...
Breaking Medicine Technology:Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 1Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 3Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 4Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 5Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 6Blood test can detect brain damage in amateur boxers 54969 1Blood test can detect brain damage in amateur boxers 54969 2A new bent on fusion 9637 1A new bent on fusion 9637 2
... Motility- MONTVALE, N.J., Oct. 25 Synvista,Therapeutics, ... publication of,preclinical data demonstrating the ability of its ... end-products (AGEs) and restore,neuronal nitric oxide synthase (nNOS) ... activity is one of the major putative mechanisms,for ...
... IIIb clinical study presented at CHEST 2007 on concomitant use ... ... treatment-, NAPA, Calif., Oct. 24 ... the American College of Chest,Physicians (ACCP), demonstrate concomitant use of nebulized ...
Other Medicine Technology:Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 2Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 3Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 2Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 3Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 4Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 5Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD 6
... stapler is a full-feature skin stapler with ... RH has improved visibility over existing fixed-head ... mechanism for easier staple placement., ,This ... use instrument designed to deliver rectangular, stainless ...
... linear stapler with LACTOMER™ 9-1 ... is a copolymer of glycolide ... Suture™ ROTICULATOR 55 POLY™ single ... use in abdominal, gynecologic, pediatric ...
... Loading Units With Titanium Staples ... TA™ (Single Use Reloadable Stapler ... Auto Suture™ PREMIUM MULTIFIRE TA™ ... gynecological, pediatric and thoracic surgical ...
... reloadable linear stapler for resection, transection and ... Suture™ MULTIFIRE GIA™ 60 and 80 single ... and 80 single use loading units and ... single use surgical stapler with MULTIFIRE SGIA™ ...
Medicine Products: